Other
Aldosterone Receptor Blockade in Heart Failure with Preserved Ejection Fraction
Abstract
More than 50% of patients with clinical heart failure have a preserved ejection fraction . Despite mortality that is similar to or slightly lower than heart failure with reduced ejection fraction , trials to date have not shown a therapy that imparts a mortality benefit in heart failure with preserved ejection fraction (HFpEF). HFpEF represents a heterogeneous disorder with a complex pathophysiologic basis, and this may contribute to the...
Paper Details
Title
Aldosterone Receptor Blockade in Heart Failure with Preserved Ejection Fraction
Published Date
Oct 1, 2018
Journal
Volume
14
Issue
4
Pages
525 - 535
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History